Published in Cloning Stem Cells on January 01, 2004
Strategies for cancer vaccine development. J Biomed Biotechnol (2010) 1.26
Comparison of gene-transfer efficiency in human embryonic stem cells. Mol Imaging Biol (2009) 1.05
Aging, cancer, and cancer vaccines. Immun Ageing (2012) 0.98
Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK. Gene Ther (2012) 0.79
Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy. Expert Opin Biol Ther (2015) 0.75
Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science (2003) 4.74
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif (2003) 4.68
Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat Genet (2003) 4.56
Dimethylation of histone H3 lysine 9 is a critical mark for DNA methylation and gene silencing in Arabidopsis thaliana. Chromosoma (2004) 3.00
gammaH2AX foci form preferentially in euchromatin after ionising-radiation. PLoS One (2007) 2.07
Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals. Chromosoma (2002) 2.03
Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J Cell Sci (2004) 1.98
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci U S A (2010) 1.84
Differential subnuclear localization and replication timing of histone H3 lysine 9 methylation states. Mol Biol Cell (2005) 1.77
Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care (2012) 1.76
Cell cycle and apoptosis. Cell Prolif (2003) 1.59
HP1gamma function is required for male germ cell survival and spermatogenesis. Epigenetics Chromatin (2010) 1.53
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist (2008) 1.47
Mitotic phosphorylation of histone H3 at threonine 3. FEBS Lett (2004) 1.46
Apoptosis: mechanisms and relevance in cancer. Ann Hematol (2005) 1.44
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol (2007) 1.44
Uncoupling global and fine-tuning replication timing determinants for mouse pericentric heterochromatin. J Cell Biol (2006) 1.41
Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev (2007) 1.40
mRNA-based gene transfer as a tool for gene and cell therapy. Curr Opin Mol Ther (2007) 1.40
The inner nuclear membrane protein lamin B receptor forms distinct microdomains and links epigenetically marked chromatin to the nuclear envelope. J Biol Chem (2004) 1.38
The effect of earplugs during the night on the onset of delirium and sleep perception: a randomized controlled trial in intensive care patients. Crit Care (2012) 1.38
Plasticity of HP1 proteins in mammalian cells. J Cell Sci (2007) 1.31
Dynamic relocation of epigenetic chromatin markers reveals an active role of constitutive heterochromatin in the transition from proliferation to quiescence. J Cell Sci (2004) 1.30
HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions. J Cell Biol (2008) 1.27
In vivo dynamics of Swi6 in yeast: evidence for a stochastic model of heterochromatin. Mol Cell Biol (2004) 1.26
Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring) (2010) 1.19
The Ki-67 protein interacts with members of the heterochromatin protein 1 (HP1) family: a potential role in the regulation of higher-order chromatin structure. J Pathol (2002) 1.18
Mammalian Polycomb Scmh1 mediates exclusion of Polycomb complexes from the XY body in the pachytene spermatocytes. Development (2007) 1.16
Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet (2003) 1.15
Fatal intoxication due to tramadol alone: case report and review of the literature. Forensic Sci Int (2007) 1.14
Regulatory T cells and human disease. Clin Dev Immunol (2007) 1.12
Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochem Biophys Res Commun (2005) 1.10
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial. Cytotherapy (2009) 1.09
Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thromb Res (2010) 1.09
Distinct roles of KAP1, HP1 and G9a/GLP in silencing of the two-cell-specific retrotransposon MERVL in mouse ES cells. Epigenetics Chromatin (2013) 1.08
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials. Oncologist (2012) 1.07
Pyoderma gangrenosum: a challenging complication of bilateral mastopexy. Int Wound J (2004) 1.06
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties. J Transl Med (2009) 1.05
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential. PLoS One (2012) 1.04
Mutations in the heterochromatin protein 1 (HP1) hinge domain affect HP1 protein interactions and chromosomal distribution. Chromosoma (2004) 1.04
The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein. Eur J Hum Genet (2011) 1.03
Methylation-independent binding to histone H3 and cell cycle-dependent incorporation of HP1beta into heterochromatin. J Biol Chem (2006) 1.02
Dendritic cell-based cancer gene therapy. Hum Gene Ther (2009) 1.02
Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect. PLoS One (2013) 1.01
Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera. Platelets (2004) 1.01
Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells. J Immunother (2006) 0.99
Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? Cell Transplant (2010) 0.98
Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol (2009) 0.98
NK cells: key to success of DC-based cancer vaccines? Oncologist (2012) 0.98
Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. Blood (2005) 0.98
A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol (1985) (2008) 0.97
Gastric perforation after cardiopulmonary resuscitation: review of the literature. Resuscitation (2010) 0.97
Components of a pathway maintaining histone modification and heterochromatin protein 1 binding at the pericentric heterochromatin in Mammalian cells. J Biol Chem (2003) 0.97
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells. Cancer Immunol Immunother (2009) 0.97
Current challenges for the advancement of neural stem cell biology and transplantation research. Stem Cell Rev (2012) 0.96
Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial. Anticancer Res (2013) 0.96
Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients. Ann Intensive Care (2011) 0.96
Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma. Anticancer Res (2010) 0.95
Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain (2009) 0.94
Neurally adjusted ventilatory assist: a ventilation tool or a ventilation toy? Respir Care (2011) 0.93
Insulin resistance and environmental pollutants: experimental evidence and future perspectives. Environ Health Perspect (2013) 0.93
Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. J Immunol (2002) 0.93
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers. Hum Vaccin (2011) 0.93
The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology? J Hazard Mater (2012) 0.93
Immunotherapy of acute myeloid leukemia: current approaches. Oncologist (2009) 0.92
Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases. Clin Neurol Neurosurg (2005) 0.92
Analysis of organophosphate flame retardant diester metabolites in human urine by liquid chromatography electrospray ionisation tandem mass spectrometry. J Chromatogr A (2013) 0.92
Exposure of the elderly to potential nephrotoxic drug combinations in Belgium. Pharmacoepidemiol Drug Saf (2008) 0.91
Successful use of fenfluramine as an add-on treatment for Dravet syndrome. Epilepsia (2012) 0.91
Dendritic cell vaccination in acute myeloid leukemia. Cytotherapy (2012) 0.91
Loss of heterochromatin protein 1 (HP1) chromodomain function in mammalian cells by intracellular antibodies causes cell death. J Cell Sci (2002) 0.90
Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol (2007) 0.90
Sewage epidemiology--a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. Environ Int (2011) 0.90
Adverse drug events in intensive care units: a cross-sectional study of prevalence and risk factors. Am J Crit Care (2011) 0.89
HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats. PLoS One (2011) 0.89
A one year investigation of the occurrence of illicit drugs in wastewater from Brussels, Belgium. J Environ Monit (2011) 0.88
NF-Y regulates the antisense promoter, bidirectional silencing, and differential epigenetic marks of the Kcnq1 imprinting control region. J Biol Chem (2004) 0.88
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS (2012) 0.88
Distribution of persistent organic pollutants in two different fat compartments from obese individuals. Environ Int (2013) 0.88
Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol (2009) 0.87